| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Global Health Clinics Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.21 |
| 52 Week Low | CA$0.01 |
| Beta | 2.48 |
| 1 Month Change | -64.29% |
| 3 Month Change | n/a |
| 1 Year Change | -75.00% |
| 3 Year Change | -99.00% |
| 5 Year Change | -99.82% |
| Change since IPO | -97.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| MJRX | CA Healthcare | CA Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.2% |
| 1Y | -75.0% | 0.7% | 6.1% |
Return vs Industry: MJRX underperformed the Canadian Healthcare industry which returned -1.1% over the past year.
Return vs Market: MJRX underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| MJRX volatility | |
|---|---|
| MJRX Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.6% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: MJRX's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MJRX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Jay Dhaliwal | globalhealthltd.ca |
Global Health Clinics Ltd. operates in the cannabis industry. The company operates medical clinics, which guide patients through the process of becoming legal users of marijuana. It develops psilocybin products for research and usage for pharmaceutical purposes.
Global Health Clinics Ltd. Fundamentals Summary
| MJRX fundamental statistics | |
|---|---|
| Market cap | CA$234.80k |
| Earnings (TTM) | -CA$1.28m |
| Revenue (TTM) | CA$88.46k |
2.7x
P/S Ratio-0.2x
P/E RatioIs MJRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MJRX income statement (TTM) | |
|---|---|
| Revenue | CA$88.46k |
| Cost of Revenue | CA$21.58k |
| Gross Profit | CA$66.88k |
| Other Expenses | CA$1.35m |
| Earnings | -CA$1.28m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 75.61% |
| Net Profit Margin | -1,445.03% |
| Debt/Equity Ratio | -45.1% |
How did MJRX perform over the long term?
See historical performance and comparison